Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101

BACKGROUND: In patients with recurrent glioblastoma, corticosteroids are frequently used to mitigate intracranial pressure and to improve patient neurological functioning. To date, in these patients, no systematic studies have been performed to assess neurocognitive functioning (NCF) in relation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Caramanna, Ivan, de Kort, Julie M, Brandes, Alba A, Taal, Walter, Platten, Michael, Idbaih, Ahmed, Frenel, Jean Sebastien, Wick, Wolfgang, Preetha, Chandrakanth Jayachandran, Bendszus, Martin, Vollmuth, Philipp, Reijneveld, Jaap C, Klein, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290884/
https://www.ncbi.nlm.nih.gov/pubmed/35855458
http://dx.doi.org/10.1093/nop/npac022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290884/
https://www.ncbi.nlm.nih.gov/pubmed/35855458
http://dx.doi.org/10.1093/nop/npac022

Ejemplares similares